Literature DB >> 19779470

Aortic pulse pressure is associated with carotid IMT in chronic kidney disease: report from Chronic Renal Insufficiency Cohort.

Stephanie S DeLoach1, Lawrence J Appel, Jing Chen, Marshall M Joffe, Crystal A Gadegbeku, Emile R Mohler, Afshin Parsa, Kalyani Perumal, Mohammed A Rafey, Susan P Steigerwalt, Valerie Teal, Raymond R Townsend, Sylvia E Rosas.   

Abstract

BACKGROUND: Patients with chronic kidney disease (CKD) have a disproportionate risk of cardiovascular disease. This study was designed to assess the association between two noninvasive measures of cardiovascular risk, pulse wave analysis (PWA), and carotid intima-media thickness (IMT), in a cohort of CKD patients enrolled in the Chronic Renal Insufficiency Cohort (CRIC) study.
METHODS: Three hundred and sixty-seven subjects with CKD enrolled in the CRIC study at the University of Pennsylvania site (mean age 59.9 years, blood pressure 129/74 mm Hg, estimated glomerular filtration rate 48 ml/min/1.73 m2, IMT 0.8 mm) had both carotid IMT and PWA measurements. Carotid ultrasound was also used to determine the presence of plaque. PWA was used to determine augmentation index (AI), amplification ratio (AMPR), aortic pulse pressure (C_PP), and central aortic systolic pressure (C_SP).
RESULTS: IMT was significantly associated with all PWA-derived measures. However, on multivariable linear regression analysis, only AMPR (regression coefficient -0.072, P = 0.006), C_PP (regression coefficient 0.0025, P < 0.001), and C_SP (regression coefficient 0.0017, P < 0.001) remained significantly associated with IMT. The prevalence of carotid plaque in the cohort was 59%. Of the PWA-derived measures, only C_PP was significantly associated with the presence of carotid plaque (P < 0.001).
CONCLUSIONS: PWA-derived measures are associated with carotid IMT and plaque in the CKD. Of these measures, C_PP was most associated with carotid IMT and plaque.

Entities:  

Mesh:

Year:  2009        PMID: 19779470      PMCID: PMC2831208          DOI: 10.1038/ajh.2009.156

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  40 in total

1.  Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames.

Authors:  R H Selzer; W J Mack; P L Lee; H Kwong-Fu; H N Hodis
Journal:  Atherosclerosis       Date:  2001-01       Impact factor: 5.162

2.  Optimization of pre-ESRD care: the key to improved dialysis outcomes.

Authors:  B J Pereira
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

3.  Arterial wave reflections and survival in end-stage renal failure.

Authors:  G M London; J Blacher; B Pannier; A P Guérin; S J Marchais; M E Safar
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

4.  Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  L E Chambless; A R Folsom; L X Clegg; A R Sharrett; E Shahar; F J Nieto; W D Rosamond; G Evans
Journal:  Am J Epidemiol       Date:  2000-03-01       Impact factor: 4.897

Review 5.  Arterial stiffness: a modifiable cardiovascular risk factor?

Authors:  Michael F O'Rourke; Junichiro Hashimoto
Journal:  J Cardiopulm Rehabil Prev       Date:  2008 Jul-Aug       Impact factor: 2.081

6.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

Authors:  D H O'Leary; J F Polak; R A Kronmal; T A Manolio; G L Burke; S K Wolfson
Journal:  N Engl J Med       Date:  1999-01-07       Impact factor: 91.245

7.  Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study.

Authors:  S Ebrahim; O Papacosta; P Whincup; G Wannamethee; M Walker; A N Nicolaides; S Dhanjil; M Griffin; G Belcaro; A Rumley; G D Lowe
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

8.  Evaluating the accuracy of an aneroid sphygmomanometer in a clinical trial setting.

Authors:  Yong Ma; Marinella Temprosa; Sarah Fowler; Ronald J Prineas; Maria G Montez; Janet Brown-Friday; Mary L Carrion-Petersen; Tracy Whittington
Journal:  Am J Hypertens       Date:  2008-12-04       Impact factor: 2.689

9.  Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II.

Authors:  Carmel M McEniery; Barry McDonnell; Margaret Munnery; Sharon M Wallace; Chloe V Rowe; John R Cockcroft; Ian B Wilkinson
Journal:  Hypertension       Date:  2008-04-21       Impact factor: 10.190

10.  Kidney function and progression of carotid intima-media thickness in a community study.

Authors:  Angela M Desbien; Michel Chonchol; Hannes Gnahn; Dirk Sander
Journal:  Am J Kidney Dis       Date:  2008-03-03       Impact factor: 8.860

View more
  13 in total

1.  Different associations between blood pressure indices and carotid artery damages in a community-based population of China.

Authors:  G Cheng; F Fan; Y Zhang; L Qi; J Jia; Y Liu; L Gao; X Han; Y Yang; Y Huo
Journal:  J Hum Hypertens       Date:  2016-07-14       Impact factor: 3.012

2.  24-hour central blood pressure and intermediate cardiovascular phenotypes in untreated subjects.

Authors:  Agnieszka Bednarek; Piotr Jankowski; Agnieszka Olszanecka; Adam Windak; Kalina Kawecka-Jaszcz; Danuta Czarnecka
Journal:  Am J Cardiovasc Dis       Date:  2014-12-29

Review 3.  The Role of Central Blood Pressure Monitoring in the Management of Hypertension.

Authors:  Adrian Ochoa; Gabriel Patarroyo-Aponte; Mahboob Rahman
Journal:  Curr Cardiol Rep       Date:  2018-04-19       Impact factor: 2.931

4.  Central pulse pressure in patients with chronic kidney disease and in renal transplant recipients.

Authors:  K P Ng; W E Moody; C D Chue; N C Edwards; T Savage; C R V Tomson; R P Steeds; J N Townend; C J Ferro
Journal:  J Hum Hypertens       Date:  2013-08-01       Impact factor: 3.012

5.  Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function.

Authors:  Enyu Imai; Seiichi Matsuo; Hirofumi Makino; Tsuyoshi Watanabe; Tadao Akizawa; Kosaku Nitta; Satoshi Iimuro; Yasuo Ohashi; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2010-08-11       Impact factor: 2.801

Review 6.  Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients.

Authors:  C Borghi; M C Acelajado; Y Gupta; S Jain
Journal:  J Hum Hypertens       Date:  2017-04-06       Impact factor: 3.012

7.  Decline of Renal Function and Progression of Left Ventricular Hypertrophy Are Independently Determined in Chronic Kidney Disease Stages 3-5.

Authors:  Hiromichi Suzuki; Tsutomu Inoue; Mami Dogi; Tomohiro Kikuta; Tsuneo Takenaka; Hirokazu Okada
Journal:  Pulse (Basel)       Date:  2014-10-31

8.  Which Measurement of Blood Pressure Is More Associated With Albuminuria in Patients With Type 2 Diabetes: Central Blood Pressure or Peripheral Blood Pressure?

Authors:  Noriyuki Kitagawa; Hiroshi Okada; Muhei Tanaka; Yoshitaka Hashimoto; Toshihiro Kimura; Koji Nakano; Masahiro Yamazaki; Goji Hasegawa; Naoto Nakamura; Michiaki Fukui
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-01-03       Impact factor: 3.738

9.  Non-invasive measurements of atherosclerosis in adult cystinosis patients.

Authors:  Martine T P Besouw; Suzanne Holewijn; Elena N Levtchenko; Mirian C H Janssen
Journal:  J Inherit Metab Dis       Date:  2011-02-09       Impact factor: 4.982

10.  Evaluation of the EndoPAT as a Tool to Assess Endothelial Function.

Authors:  M Moerland; A J Kales; L Schrier; M G J van Dongen; D Bradnock; J Burggraaf
Journal:  Int J Vasc Med       Date:  2012-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.